Microbiología y Parasitología
Departamento
Germán
Bou Arévalo
Publicaciones en las que colabora con Germán Bou Arévalo (29)
2024
-
In vitro activity of cefiderocol and other newly approved antimicrobials against multi-drug resistant Gram-negative pathogens recovered in intensive care units in Spain and Portugal
Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 1, pp. 69-77
2023
-
Corrigendum: CARB-ES-19 multicenter study of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli from all Spanish provinces reveals interregional spread of high-risk clones such as ST307/OXA-48 and ST512/KPC-3(Front. Microbiol., (2022), 13, (918362), 10.3389/fmicb.2022.918362)
Frontiers in Microbiology
-
Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 6, pp. 360-370
2022
-
CARB-ES-19 Multicenter Study of Carbapenemase-Producing Klebsiella pneumoniae and Escherichia coli From All Spanish Provinces Reveals Interregional Spread of High-Risk Clones Such as ST307/OXA-48 and ST512/KPC-3
Frontiers in Microbiology, Vol. 13
-
Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults
Antibiotics, Vol. 11, Núm. 9
-
Imipenem-Relebactam Susceptibility in Enterobacterales Isolates Recovered from ICU Patients from Spain and Portugal (SUPERIOR and STEP Studies)
Microbiology spectrum, Vol. 10, Núm. 5, pp. e0292722
-
In Vitro Activity of Cefepime-Taniborbactam against Carbapenemase-Producing Enterobacterales and Pseudomonas aeruginosa Isolates Recovered in Spain
Antimicrobial Agents and Chemotherapy, Vol. 66, Núm. 3
-
In vitro activity of imipenem/relebactam against Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal (SUPERIOR and STEP studies)
The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 11, pp. 3163-3172
-
Justification for 24/7 clinical microbiology services
Enfermedades Infecciosas y Microbiologia Clinica
-
Multicenter Performance Evaluation of MALDI-TOF MS for Rapid Detection of Carbapenemase Activity in Enterobacterales: The Future of Networking Data Analysis With Online Software
Frontiers in Microbiology, Vol. 12
2021
-
Distinct epidemiology and resistance mechanisms affecting ceftolozane/tazobactam in Pseudomonas aeruginosa isolates recovered from ICU patients in Spain and Portugal depicted by WGS
The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 2, pp. 370-379
-
Fundamentals and implementation of Microbiological Diagnostic Stewardship Programs
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 39, Núm. 5, pp. 248-251
-
Predicting Pseudomonas aeruginosa susceptibility phenotypes from whole genome sequence resistome analysis
Clinical Microbiology and Infection, Vol. 27, Núm. 11, pp. 1631-1637
2020
-
(p)ppGpp and its role in bacterial persistence: New challenges
Antimicrobial Agents and Chemotherapy, Vol. 64, Núm. 10
-
In vitro and in vivo efficacy of combinations of colistin and different endolysins against clinical strains of multi-drug resistant pathogens
Scientific Reports, Vol. 10, Núm. 1
-
Recommendations of the Spanish Antibiogram Committee (COESANT) for selecting antimicrobial agents and concentrations for in vitro susceptibility studies using automated systems
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 38, Núm. 4, pp. 182-187
-
Temperate Bacteriophages (Prophages) in Pseudomonas aeruginosa Isolates Belonging to the International Cystic Fibrosis Clone (CC274)
Frontiers in Microbiology, Vol. 11
-
WGS characterization of MDR Enterobacterales with different ceftolozane/tazobactam susceptibility profiles during the SUPERIOR surveillance study in Spain
JAC-Antimicrobial Resistance, Vol. 2, Núm. 4
2019
-
Activity of ceftolozane/tazobactam against Pseudomonas aeruginosa and Enterobacterales isolates recovered from intensive care unit patients in Spain: The SUPERIOR multicentre study
International Journal of Antimicrobial Agents, Vol. 53, Núm. 5, pp. 682-688
2018
-
Activity of ceftazidime-avibactam against carbapenemase-producing Enterobacteriaceae from urine specimens obtained during the infection-carbapenem resistance evaluation surveillance trial (iCREST) in Spain
International Journal of Antimicrobial Agents, Vol. 51, Núm. 3, pp. 511-515